Elevai Labs Inc. Common S... (ELAB)
2.12
-0.19 (-8.23%)
At close: Jan 15, 2025, 1:41 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -4.30M | -1.80M | -784.74K | -222.91K |
| Depreciation & Amortization | 11.65K | 6.51K | 2.76K | n/a |
| Stock-Based Compensation | 487.74K | 171.87K | 142.35K | n/a |
| Other Working Capital | -1.00M | 28.12K | -51.82K | 7.39K |
| Other Non-Cash Items | 68.51K | 224.16K | 118.56K | -1.04K |
| Deferred Income Tax | n/a | n/a | n/a | n/a |
| Change in Working Capital | -823.19K | 12.43K | -21.91K | 6.79K |
| Operating Cash Flow | -4.56M | -1.59M | -660.93K | -217.16K |
| Capital Expenditures | -11.19K | -35.53K | -32.48K | n/a |
| Acquisitions | n/a | 3.50K | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 3.50K | n/a | n/a |
| Investing Cash Flow | -11.19K | -32.03K | -32.48K | n/a |
| Debt Repayment | n/a | 183.97K | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -724.70K | 2.18M | 1.09M | 238.28K |
| Financial Cash Flow | 6.74M | 2.36M | 1.09M | 238.28K |
| Net Cash Flow | 2.17M | 743.04K | 398.51K | 19.61K |
| Free Cash Flow | -4.57M | -1.62M | -693.41K | -217.16K |